[go: up one dir, main page]

WO2019240671A1 - Manufacturing method for benznidazole production and the industrial scaling thereof - Google Patents

Manufacturing method for benznidazole production and the industrial scaling thereof Download PDF

Info

Publication number
WO2019240671A1
WO2019240671A1 PCT/SV2019/000002 SV2019000002W WO2019240671A1 WO 2019240671 A1 WO2019240671 A1 WO 2019240671A1 SV 2019000002 W SV2019000002 W SV 2019000002W WO 2019240671 A1 WO2019240671 A1 WO 2019240671A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
synthesis method
iii
carried out
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/SV2019/000002
Other languages
Spanish (es)
French (fr)
Other versions
WO2019240671A4 (en
Inventor
Erlinda HANDAL VEGA
Carmen Elena ARIAS RIVAS
Ana Karina CUCHILLA DE MERLOS
David Alfredo SERVELLON CARPIO
Mauricio Manuel SILVESTRA MESTRA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ministerio De Educacion Ciencia Y Tecnologia
Original Assignee
Ministerio De Educacion Ciencia Y Tecnologia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ministerio De Educacion Ciencia Y Tecnologia filed Critical Ministerio De Educacion Ciencia Y Tecnologia
Publication of WO2019240671A1 publication Critical patent/WO2019240671A1/en
Publication of WO2019240671A4 publication Critical patent/WO2019240671A4/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals

Definitions

  • the present invention relates to an organic synthesis method, under the green chemistry approach, for obtaining an imidazole derived molecule, with antiparasitic activity against trypanosome cruzi.
  • GB 1138529 presents the synthesis of imidazole derivatives among which N-benzyl-2- (2-nitro-1 H-imidazol-1-yl appears) ) Acetamide (Benznidazole), for this compound describe the synthesis procedure from sodium methoxide / methanol, adding 2-nitroimidazole dissolved in N, N-dimethylformamide, the mixture is heated to 153 ° C to remove methanol. Subsequently, the 2-chloro-methyl acetate ester is added, the temperature of the reaction mixture drops to 122 ° C and then the formation of a precipitate occurs, the formed mixture is heated between 105 ° C and 1 15 ° C.
  • the solvent is discarded in a bath at 50 ° C and reduced pressure 0.2 mm Hg and the solid formed is recrystallized from ethanol, the methyl 2- [2-nitroimidazol- (1) -yl] acetate ester is obtained.
  • the methyl 2- [2-nitroimidazol- (1) -yl] acetate ester is treated with benzylamine dissolved in absolute methanol, left at room temperature overnight. The mixture was refrigerated for several hours and the crystals formed are collected by filtration, these crystals have a melting point 187.5 ° C at 189.5 ° C.
  • GB 1138529 describes a series of procedures for obtaining benznidazole, which include synthetic steps in the presence of heating and solvents such as methanol, N, N-dimethylformamide, which leads to procedures for removing solvents. In our invention no organic solvents are used and it does not require applying heat for any synthesis step. Pérez Eduardo, et al. An Easy and Efficient Microwave Assisted Method to Obtain 1- (4-Bromophenacyl) azoles in “Dry Media”. Heterocycles, Vol. 43, N 9 3, 1996.
  • Pérez Eduardo; et al refer to the use of a halide which is an a-bromo ketone (4-bromophenacyl bromide), presenting a carbon a, which is more easily reversed due to its polarity, because the carbon that supports bromine has Adjacent position a ketone group that influences polarity inversion and may favor / V-alkylation. While the present invention works with the / V-benzyl-2-chlorbacetamide, which contains a chlorine instead of bromine, the chlorine has less ease as a leaving group and the carbon that supports it has an adjacent amide functional group which does not favor the reversal of polarity as does the ketone group.
  • PTC phase transfer catalysis
  • Figure 3 Scheme of the reactions of the five-membered ring azaheterocyclics with the corresponding alkyl halides under microwave irradiation. Described by Dariusz
  • the reaction is verified by a mixture of the azheterocyclic compound (5 mmol), with the corresponding alkyl halide (7.5 mmol), tetrabutylammonium bromide-TBAB (0.17 g, 0.50 mmol), and potassium carbonate (2.8 g, 20 mmol) , or mixture of potassium carbonate (2.8 g, 20 mmol) and potassium hydroxide (1.1 g, 20mmol), the mixture is heated in a domestic microwave oven. After cooling the reaction mixture is extracted with methylene chloride or tetrahydrofuran. The extract is dried with magnesium sulfate, filtered and the solvent is evaporated.
  • Our invention unlike Dariusz Bogdal, et al., Is carried out without applying any type of heating, it develops under mild conditions, it does not require the use of microwaves, it does not require the presence of a base such as KOH.
  • the Azo Route figure 4.1 It was used as the starting compound imidazole 9, the strategy presented by Gandolfi Donad ⁇ o, L et al., Consists of introducing the nitrogen functionality by coupling between 9 and 8 to give the azoderivative 10. Then it presents the reduction of 10, to form an aminoimidazole derivative 15 in the presence of Pd (black) and formic acid. Oxidation via diazonium salt of 15 forms a mixture containing 2-chloroimidazole. According to the publication, derivatives 19 and 24 were synthesized in good yields and various reaction conditions were tested to obtain compound 20 without satisfactory results.
  • the routes proposed in Gandolfi Donad ⁇ o, L et al present a series of steps that involve various reagents and heating conditions and the formation of several intermediary products.
  • the present invention is carried out by reacting N-be ⁇ yl-2-chloroacetamide with 2-nitroimidazole, using tetrabutylammonium bromide (TBAB) and potassium carbonate (K2CO3) as catalyst.
  • TBAB tetrabutylammonium bromide
  • K2CO3 potassium carbonate
  • Hernandez-Nu ⁇ ez, Emanuel et al. They describe that by means of the bimolecular nucleophilic substitution reaction they obtain a series of ⁇ niidazolic derivatives, / V-acetamide (sulfonamide) -2-methyl-4-nitroimidazoles, of general structure (i) and (i) according to figure 6.
  • Imidazole derivatives of the general formula (i) were prepared from anion 4 (5) -nitro-2-methyl-1 / - / - imidazole by a bimolecular nucleophilic substitution, using potassium carbonate and acetonitrile.
  • the general method of synthesis is carried out with dissolution of 4 (5) -nitro-2-methyl-1 / - / - imidazole and potassium hydroxide, to generate anion 4 (5) -nitro-2-methyl-1 H-imidazole in the presence of acetonitrile. This solution is stirred for 30 minutes and to this mixture is added substituted a-chloroacetamide, dissolved in acetonitrile. It is stirred and heated at reflux for 8 hours.
  • Imidazole derivatives of the general formula (i) were prepared via coupling reaction from anion 4 (5) -nitro-2-methyl-1 / - / - imidazole with arylsulfonyl chlorides, in the presence of potassium hydroxide, 4 -dimethylaminopyridine (catalyst) and triethylamine.
  • Hernandez-Nunez, Emanuel et to the, has substituted derivatives -NO2 group 3 or 4 carbon substituent and methyl (-CH 3) carbon 2.
  • US Patent 9,765,036 B2 presents a method of preparing / V-benzyl-2- (2-nitro-1 H-imidazol-1-yl) acetamide using as materials ; initials N-benzyl-1-hydroxyacetamide and 2-nitroimidazole in the solid state and in the absence of solvent.
  • the procedure occurs by mixing the two initial materials and activating by microwave irradiation to form the N-benzyl-2- (2-nitro-tH-imidazol-1-yl) acetamide.
  • the reaction mixture is purified on a chromatography column, using alumina as the stationary phase and ethyl acetate as the mobile phase: The method does not require acid catalysts or bases in the synthesis process.
  • Patent application WO 2017/205622 A1 presents a method for preparing benznidazole by reacting 2-nitroimidazole (1.5 g) of formula 1 in figure 7, potassium carbonate (6.72 g) and bromine ethyl acetate (8 , 12 g, 5; 39 mL) of formula 2 in Figure 7, heated at 70 ° C for 110 minutes, this reaction mixture is cooled to 50 ° C and benzylamine is added, the suspension is stirred for 16 hours. Water (50 mL) is added, the reaction mass is cooled from 0 to 5 ° C and stirred for 2 hours, filtered and wash with 25 mL of cold water. Benznidazole of formula 3 in Figure 7 is obtained as a solid paste.
  • the solid paste is dried under vacuum and at 50 ° C for 16 hours and the benznidazole of formula 3 in figure 7 is obtained as a pale yellow solid, 10.01 g (87%).
  • the benznidazole formula 3 in figure 7 is recrystallized with a mixture of acetone: methanol: water (49.9 mL, 49.9 mL, 5.3 mL).
  • benznidazole is prepared from 2- nitroimidazole and acetate halide ester, where the halide can be bromine, iodine and chlorine where R (of the alkoxide group) can be methyl, ethyl, isopropyl , neobutyl, butyl and terbutyl, preferably use ethyl bromoacetate as the ester, carrying out the reaction in the presence of potassium carbonate, by means of a series of steps that require heating and cooling.
  • benznidazole in the form of a solid paste that requires subsequent recrystallization process.
  • the present invention deals with a method of synthesis for the production of Benznidazole or / V-benzyl-2- (2-nitro-1 H-imidazol-1-yl) acephalamide of formula (I), of high purity,
  • the molar ratio of the molecule of formula (II) and carbonate of. Potassium (K 2 GQ 3 ) is from one to one to one to six, respectively.
  • the second reaction route consisted of carrying out the synthesis in the presence of solvent, reacting 2-nitroimidazole of formula (II) with / V-benCyl-2-chloroacetamide of formula (III), followed by the addition of potassium carbonate and tetrabutylammonium bromide, subsequently adding water to obtain a homogeneous reaction mixture.
  • the mother liquor obtained from the synthesis has been reused to carry out another process of the same synthesis, in some cases adding only 2-nitroimidazo and A / -benzyl-2-chloroacetamide.
  • the second reaction state requires the addition of potassium carbonate. Obtaining high purity benznidazole.
  • This reaction is carried out as follows: 2-Nitroimidazole (1.0 g, 8.8 x 10 3 moles) is mixed with 1 / V-benzyl-2-chloroacetamide (1,764 g, 9.7 x 10 3 moles), in the absence of solvent. When the mixture is homogenized, tetrabutylammonium bromide (2.85 g 0, 8.8 x 10 ⁇ moles), is added and mixing is continued subsequently added carbonate- potassium (4.8892 g, 3.5 x 10 '2 moles). The reaction mixture is allowed to stand up to 72 hours. The synthesis product is isolated by performing water washes to neutral pH.
  • benznidazole was performed by TLC analysis, high performance liquid chromatography with photodiode array detector ( Figure 1 of annexes), corresponding to the retention time with reference standard, gas chromatography coupled to mass spectrometry corresponding time Withholding in the chromatogram and the mass spectrum with the reference standard, infrared spectroscopy was performed presenting signals of its spectrum that coincide with the signals of the reference standard.
  • 2-Nitroimidazole (1.0 g, 8.8 x 10 3 moles) is mixed with / V-benzyl-2-chloroacetamide (1,764 g, 9.7 x 10 3 moles) in the absence of solvent. Guando the mixture is homogenized, potassium carbonate, K2CO3 (4.8892 g, 3.5 x 10 is added '2 moles), mixing is continued subsequently tetrabutylammonium bromide (2.8510 g, 8.8 x 10 adds' 3 moles). The reaction mixture is allowed to stand up to 72 hours. The synthesis product is isolated by performing water washes to neutral pH.
  • the benznidazole obtained was analyzed by TLC, high resolution liquid cryography with photodiode array detector ( Figure 2 of years), corresponding to the retention time with reference standard, gas chromatography coupled to mass spectrometry corresponding the retention time in the chromatogram and the mass spectrum with the reference pattern, infrared spectroscopy was performed presenting signals of its spectrum that coincide with the signals of the reference pattern.
  • 2-Nitroimidazole (5.0 g, 4.4 x 10 -2 moles) is mixed with. / y-benzyl-2-chloroacetamide (8.932 g, 4.8 x 10 '2 moles) in absence of solvent.
  • potassium carbonate 24,446 g, 1.7 x 10 '1 mol
  • tetrabutylammonium bromide 14.225 g, 4.4.x 10 _1 moles
  • the benznidazole obtained was analyzed by TLC, high performance liquid chromatography with photodiode array detector, corresponding to the retention time with standard of reference, gas chromatography coupled to mass spectrometry corresponding retention time in the chromatogram was performed infrared spectroscopy spectrum showing signals matching 'with the signal reference pattern.
  • 2-nitroimidazole (5.0 g, 4.4 x 10 2 moles) is added to a container containing water, then potassium carbonate (24,446 g, 1.7 x 10 1 moles) is added, mixing is continued until it forms a Homogeneous mixture, then / / / - benzyl-2-chloroacetamide (8,932 g, 4.8 x 10 2 moles) is added. Finally, tetrabutylammonium bromide (4.225 g, 4.4 x 10 1 mol) is added. The reaction mixture is continued stirring up to 72 hours. The synthesis product is isolated by performing water washes to neutral pH.
  • the benznidazole obtained was analyzed by TLC, high performance liquid chromatography with photodiode array detector ( Figure 3 of annexes), corresponding to the retention time with reference standard, gas chromatography coupled to mass spectrometry corresponding to retention time in the chromatogram and the mass spectrum with the reference pattern, infrared spectroscopy was performed presenting signals of its spectrum that coincide with the signals of the reference pattern.
  • This reaction is carried out as follows: In the presence of agitation, potassium carbonate (12.2219 g, 8.8 x 10 2 moles) is dissolved in water, then 2-nitroimidazole (5.0 g, 4.4 x ID 2 moles) is added until Complete solution is subsequently added A / -benzyl-2-doroacetamide (8,932 g, 4.8 x 10 2 moles), stirring is continued until homogeneous mixing. Finally, tetrabutylammonium bromide (14,225 g, 4.4 x 10 1 mol) is added. The reaction mixture is stirred for up to 72 hours. The synthesis product is isolated by performing water washes to neutral pH.
  • This reaction is carried out as follows: In the presence of agitation, it is dissolved in potassium carbonate water (6.1110 g, 4.4 x 10 2 moles), then 2-nitroimidazole (5.0 g, 4.4 x 10 :? Moles) is added until complete dissolution, N-bendl-2-chloroacetamide (8,932 g, 4.8 x 10 2 moles) is added until stirring is continued until homogeneous mixing. Finally, tetrabutylammonium bromide (14,225 g, 4.4 x 10: 1 mol) is added. The reaction mixture is continued stirring up to 72 hours. The synthesis product ' is. isolated by performing water washes to neutral pH.
  • the benznidazole obtained was analyzed by TLC, high performance liquid chromatography with photodiode array detector V ( Figure 8 of annexes), corresponding to the retention time with reference standard, gas chromatography coupled to corresponding mass spectrometry. ' the retention time in the chromatogram and the mass spectrum with the reference pattern, infrared spectroscopy was performed presenting signals of its spectrum that coincide with the signals of the reference pattern. Execution example 10.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The present invention relates to a chemical synthesis method for obtaining benznidazole, or N-benzyl-2-(2-nitro-1H-imidazole-1-yl)acetamide, and to the industrial scaling thereof. It is a simple method that can be easily and safely manipulated and provides a high-yield high-purity product. The method can be carried out in the absence of a solvent and can also be carried out using water as a solvent, with the possibility of reusing the mother liquor in another synthesis method, when the process is carried out in an aqueous medium.

Description

Método de Manufactura para la Producción de Benznidazol y su Escalado  Manufacturing Method for the Production of Benznidazole and its Scaling

Industrial  Industrial

Sector tecnológico. Technology Sector

La presente invención se refiere a un método de síntesis orgánica, bajo el enfoque de química verde, para la obtención de una molécula derivado imidazólico, con actividad antiparasitaria contra tripanosoma cruzi. The present invention relates to an organic synthesis method, under the green chemistry approach, for obtaining an imidazole derived molecule, with antiparasitic activity against trypanosome cruzi.

Estado del arte. State of the art

Relacionado con el tema de la presente invención, se encuentran los documentos que comentamos a continuación: GB 1138529, presenta la síntesis de derivados imidazólicos entre los que aparece N- bencil-2-(2-nitro-1 H-imidazol-1-il)acetamida (Benznidazol), para este compuesto describen el procedimiento de síntesis a partir metóxido de sodió/metanol, adicionando 2-nitroimidazol disuelto en N,N-dimetilformamida, se calienta la mezcla a 153°C para remover el metanol. Posteriormente se agrega el éster 2-cloro-acetato de metilo, la temperatura de la mezcla de reacción desciende a 122°C y¡ posteriormente ocurre la formación de un precipitado, la mezcla formada se calienta éntre 105°C y 1 15°C. El disolvente se descarta en un baño a 50°C y presión reducida 0.2 mm de Hg y el sólido formado es recristalizado en etanol, se obtiene el éster 2-[2-nitroimidazol-(1 )-il]acetato de metilo. El éster 2-[2-nitroimidazol-(1)-il]acetato de metilo es tratado con bencilamina disuelta en metanol absoluto, se dejó a temperatura ambiente durante la noche. La mezcla fue refrigerada por varias horas y los cristales formados se colectan por filtración, estos cristales poseen un punto de fusión 187.5°C a 189.5°C. El filtrado fue concentrado bajo presión reducida y el sólido obtenido fue recristalizado en acetato de etilo, dando un material adicional de punto de fusión 187.5°C a 189°C. La recristalización en etanol da A/-bencil-2-(2-nitro-1 H-imidazol-1-il)acetamida, en forma de cristales de punto de fusión 188.5°C a 190°C . Related to the subject of the present invention, are the documents that we comment below: GB 1138529, presents the synthesis of imidazole derivatives among which N-benzyl-2- (2-nitro-1 H-imidazol-1-yl appears) ) Acetamide (Benznidazole), for this compound describe the synthesis procedure from sodium methoxide / methanol, adding 2-nitroimidazole dissolved in N, N-dimethylformamide, the mixture is heated to 153 ° C to remove methanol. Subsequently, the 2-chloro-methyl acetate ester is added, the temperature of the reaction mixture drops to 122 ° C and then the formation of a precipitate occurs, the formed mixture is heated between 105 ° C and 1 15 ° C. The solvent is discarded in a bath at 50 ° C and reduced pressure 0.2 mm Hg and the solid formed is recrystallized from ethanol, the methyl 2- [2-nitroimidazol- (1) -yl] acetate ester is obtained. The methyl 2- [2-nitroimidazol- (1) -yl] acetate ester is treated with benzylamine dissolved in absolute methanol, left at room temperature overnight. The mixture was refrigerated for several hours and the crystals formed are collected by filtration, these crystals have a melting point 187.5 ° C at 189.5 ° C. The filtrate was concentrated under reduced pressure and the solid obtained was recrystallized from ethyl acetate, giving an additional melting point material 187.5 ° C at 189 ° C. Recrystallization from ethanol gives A / -benzyl-2- (2-nitro-1 H-imidazol-1-yl) acetamide, as melting point crystals 188.5 ° C at 190 ° C.

GB 1138529, describe una serie de procedimientos para obtener benznidazol, los que incluyen pasos de síntesis en presencia de calentamiento y disolventes como metanol, N,N-dimetilformamida, lo que conlleva a procedimientos para remover los disolventes. En nuestra invención no se utilizan disolventes orgánicos y no requiere aplicar calor para ningún paso de síntesis. Pérez Eduardo, et al. An Easy and Efficient Microwave Assisted Method to Obtain 1-(4-Bromophenacyl)azoles in “Dry Media”. Heterocycles, Vol. 43, N9 3, 1996. Describen un método fácil y eficiente para obtener cinco compuestos 1- (4-Bromofenacil) azoles obteniéndose en condiciones libres de disolvente, en ausencia de base y en relación molar 1 :1 del bromuro de 4-bromofenilacilo con los siguientes compuestos: pirazol (1 a), 3,5-dimetilpirazol (1 b) , 1 ,2,4-triazol (1c), indazol (2d), ó benzotriazol (2e), bajo irradiación microondas. GB 1138529 describes a series of procedures for obtaining benznidazole, which include synthetic steps in the presence of heating and solvents such as methanol, N, N-dimethylformamide, which leads to procedures for removing solvents. In our invention no organic solvents are used and it does not require applying heat for any synthesis step. Pérez Eduardo, et al. An Easy and Efficient Microwave Assisted Method to Obtain 1- (4-Bromophenacyl) azoles in “Dry Media”. Heterocycles, Vol. 43, N 9 3, 1996. Describe an easy and efficient method to obtain five compounds 1- (4-Bromofenacil) azoles obtained under solvent-free conditions, in the absence of base and in 1: 1 molar ratio of bromide of 4-bromophenylacil with the following compounds: pyrazole (1 a), 3,5-dimethylpyrazole (1 b), 1, 2,4-triazole (1c), indazole (2d), or benzotriazole (2e), under microwave irradiation .

Las ecuaciones para las reacciones entre bromuro de 4-bromofénilacilo y (1a), (1 b), y (1 c), se presentan en la fig. 1. The equations for reactions between 4-bromophenylacetyl bromide and (1a), (1 b), and (1 c), are presented in fig. 1.

Figure imgf000003_0001
Figure imgf000003_0001

Las ecuaciones para las reacciones entre bromuro de 4-bromofenacilo y (2d), o (2e), se presentan en la fig. 2.  The equations for the reactions between 4-bromofenacil bromide and (2d), or (2e), are presented in fig. two.

Figure imgf000003_0002
Figure imgf000003_0002

(2e> ( 2e >

Figura 2 . Esquema de reacciones entre bromuro de 4-bromofenacilo y (2d), (2e), descritos por  Figure 2 Scheme of reactions between 4-bromophenacyl bromide and (2d), (2e), described by

Pérez Eduardo, et al. En todos los casos planteados el producto A/-alquilado en posición 1 , con respecto ai anillo heterociclo, es obtenido como producto principal dé la síntesis, como consecuencia de la ausencia de disolvente, que podría permitir un equilibrio tautomérico y la relación molar 1 :1 de los reactantes que minimiza el fenómeno de cuáternarización. En Pérez Eduardo, et al., las reacciones son llevadas a cabo en ausencia de disolvente y se utiliza como fuente de calentamiento microondas, mientras que la presente invención se lleva a cabo en ausencia disolvente orgánico y sin aplicar irradiación microondas o algún otro tipo de calentamiento. Pérez Eduardo; et al, refieren al uso de un haluro que es una a-bromocetona (bromuro de 4-bromofenacilo), presentando un carbono a, que posee mayor facilidad para la inversión de su polaridad debido, a que el carbono que soporta al bromo posee en posición adyacente un grupo cetona que influye en la inversión de la polaridad y puede favorecer la /V-alquilación. Mientras que en la presente invención invención se trabaja con la /V-bencil-2-clorbacetamida, que contiene un cloro en lugar de bromo, el cloro presenta menor facilidad como grupo saliente y el carbono que lo soporta tiene adyacente un grupo funcional· amida que no favorece la inversión de la polaridad como lo hace el grupo cetona. Pérez Eduardo, et al. In all the cases raised, the A / -alkylated product in position 1, with respect to the heterocycle ring, is obtained as the main product of the synthesis, as a consequence of the absence of solvent, which could allow a tautomeric equilibrium and the molar ratio 1: 1 of the reactants that minimizes the phenomenon of quaternization. In Pérez Eduardo, et al., The reactions are carried out in the absence of solvent and used as a microwave heating source, while the present invention is carried out in the absence of organic solvent and without applying microwave irradiation or some other type of heating. Pérez Eduardo; et al, refer to the use of a halide which is an a-bromo ketone (4-bromophenacyl bromide), presenting a carbon a, which is more easily reversed due to its polarity, because the carbon that supports bromine has Adjacent position a ketone group that influences polarity inversion and may favor / V-alkylation. While the present invention works with the / V-benzyl-2-chlorbacetamide, which contains a chlorine instead of bromine, the chlorine has less ease as a leaving group and the carbon that supports it has an adjacent amide functional group which does not favor the reversal of polarity as does the ketone group.

Dariusz Bogdal, et al. Remarkable Fast N-Alquilation of Azaheterocycles under Microwave Irradiatión in Dry Media. Heterocycles, Vol. 45, N° 4, 1997. Muestra un método general de /V-alquilación de heterociclos que poséan un hidrógeno ácido. Manteniendo la conveniencia de los métodos de catálisis por transferencia de fase (PTC), pero aplicando calentamiento por microondas en condiciones libres de disolventes. Dariusz Bogdal, et al. Remarkable Fast N-Alquilation of Azaheterocycles under Microwave Irradiation in Dry Media. Heterocycles, Vol. 45, No. 4, 1997. It shows a general method of / V-alkylation of heterocycles that have an acidic hydrogen. Maintaining the convenience of phase transfer catalysis (PTC) methods, but applying microwave heating under solvent-free conditions.

Presentan un método rápido de síntesis de /V-alquilazaheterociclos en medios "secos" bajo irradiación de microondas según Fig. 3. They present a rapid method of synthesis of / V-alkylaryl heterocycles in "dry" media under microwave irradiation according to Fig. 3.

Irradiación Irradiation

Figure imgf000004_0001
Figure imgf000004_0001

X = Cl, Br, I, TBAB: bromuro de tetrabutilamonio X = Cl, Br, I, TBAB: tetrabutylammonium bromide

Figura 3.. Esquema de las reacciones de los azaheteroclclicos de anillo de cinco miembros con los correspondientes haluros de alquilos bajo irradiación de microondas. Descritos por Dariusz Figure 3 .. Scheme of the reactions of the five-membered ring azaheterocyclics with the corresponding alkyl halides under microwave irradiation. Described by Dariusz

Bogdal, et al. Dariusz Bogdal, et al. también presentan resultados para las reacciones de los compuestos azaáromáticos con anillos fusionados mostradas en la Fig. 3. Bogdal, et al. Dariusz Bogdal, et al. they also present results for the reactions of the azaromatic compounds with fused rings shown in Fig. 3.

Figure imgf000005_0001
Figure imgf000005_0001

I Irradiación Microondas  I Microwave Irradiation

R l -10 in; 58-95 %

Figure imgf000005_0002
R 1 -10 in; 58-95%
Figure imgf000005_0002

K2C03 / OH / TBAB K 2 C0 3 / OH / TBAB

Z = C: indol; Z = N: benzimidazol; TBAB: bromuro de tetr butilamonio.  Z = C: indole; Z = N: benzimidazole; TBAB: tetr butylammonium bromide.

Figura 4. Reacciones entre el haluro de alquilo y compuestos azaheteroclclicos de cinco miembros fusionados a anillos bencénico y bajo irradiación micróóhdas. Descritos por Dariusz  Figure 4. Reactions between alkyl halide and five-membered azaheterocyclic compounds fused to benzene rings and under microhyde irradiation. Described by Dariusz

Bogdal, et ai.  Bogdal, et ai.

La reacción se verifica de una mezcla del compuesto ázahetérócíclico (5 mmol), con el correspondiente haluro de alquilo (7.5 mmol), bromuro de tetrábutilamonio - TBAB (0.17 g, 0.50 mmol), y carbonato de potasio (2.8 g, 20 mmol), o mezcla de carbonato de potasio (2.8 g, 20 mmol) e hidróxido de potasio (1.1 g, 20mmól), la mezcla es calentada en un horno microondas doméstico. Después de enfriar la mezcla de reacción se extrae con cloruro de metileno o tetrahidrofurano. El extracto se seca con sulfato de magnesio, se filtra y el disolvente es evaporado. Nuestra invención a diferencia de Dariusz Bogdal, et al., se lleva a cabo sin aplicar algún tipo de calentamiento, se desarrolla en condiciones suaves déTémpieratura, no requiere uso de las microondas, no requiere de la presencia de una báse como KOH. The reaction is verified by a mixture of the azheterocyclic compound (5 mmol), with the corresponding alkyl halide (7.5 mmol), tetrabutylammonium bromide-TBAB (0.17 g, 0.50 mmol), and potassium carbonate (2.8 g, 20 mmol) , or mixture of potassium carbonate (2.8 g, 20 mmol) and potassium hydroxide (1.1 g, 20mmol), the mixture is heated in a domestic microwave oven. After cooling the reaction mixture is extracted with methylene chloride or tetrahydrofuran. The extract is dried with magnesium sulfate, filtered and the solvent is evaporated. Our invention, unlike Dariusz Bogdal, et al., Is carried out without applying any type of heating, it develops under mild conditions, it does not require the use of microwaves, it does not require the presence of a base such as KOH.

Gandolfi Donadío, L et al. Desarrollo de nuevas tecnologías para la producción de benznidazol. En: TecnoINTI edición 2013; 11 Jornadas Abiertas de Desarrollo, Innovación y Transferencia de Tecnología. 2-4 julio 2013, Buenos Aires. Editado por Instituto Nacional de Tecnología Industrial. Buenos Aires, octubre, 2013, 1 a edición, página 218, ISBN 978-950-532-202-2. Describe reacciones para la síntesis del Benznidazol siguiendo tres rutas alternativas: Ruta Azo (Fig. ¼:T);-Ruta Imidazolona (Fig. 4.2) y Ruta 2-metil-tiOrimidazol (Fig. 4.3). Gandolfi Donadío, L et al. Development of new technologies for the production of benznidazole. In: TecnoINTI edition 2013; 11 Open Days of Development, Innovation and Technology Transfer. 2-4 July 2013, Buenos Aires. Edited by the National Institute of Industrial Technology. Buenos Aires, October, 2013, 1st edition, page 218, ISBN 978-950-532-202-2. It describes reactions for the synthesis of Benznidazole following three alternative routes: Azo Route (Fig. ¼: T); - Imidazolone Route (Fig. 4.2) and Route 2-methyl-thi-Orimidazole (Fig. 4.3).

4 .1 Ru

Figure imgf000006_0002
Figure imgf000006_0001
4 .1 Ru
Figure imgf000006_0002
Figure imgf000006_0001

Figure imgf000006_0003
Figure imgf000006_0003

Figura 4.1. Ruta Azo 2. Ruta Imidazolona

Figure imgf000006_0004
Figure imgf000006_0005
Figure 4.1. Azo Route 2. Imidazolone Route
Figure imgf000006_0004
Figure imgf000006_0005

Figura 4.2. Ruta Imidazolona Figure 4.2. Imidazolone Route

4. 3. Ruta 2-metil-tio-imidazol 4. 3. Route 2-methyl-thio-imidazole

OI MVe OI MVe

Me + KSCN HCI M e + KSCN HCI

HN 1 N. Mel  HN 1 N. Mel

H2N^ 0 H ^NH · . NH?OH.HCI G H 2 N ^ 0 H ^ NH ·. NH ? OH.HCI G

Hi m reflujo W Acetona K2C03 Hi m reflux W Acetone K 2 C0 3

21 22  21 22

23 75% (2 pasos) 24 EtOH w  23 75% (2 steps) 24 EtOH w

20  twenty

Figure imgf000007_0001
Figure imgf000007_0001

Figura 4.3. Ruta 2-metil-tio-imidazol  Figure 4.3. 2-methyl-thio-imidazole route

La Ruta Azo figura 4.1. Se utilizó como compuesto de partida imidazol 9, la estrategia presentada por Gandolfi Donadío, L et al., consiste en introducir la funcionalidad nitrogenada por copulación entre 9 y 8 para dar el azoderivado 10. Después presenta la reducción de 10, para formar un aminoimidazol derivado 15 en presencia de Pd (black) y ácido fórmico. La oxidación vía sal de diazonio de 15, forma una mezcla que contiene 2-cloroimidazol. Según la publicación, se sintetizaron los derivados 19 y 24 con rendimientos buenos y se ensayaron varias condiciones de reacción para obtener el compuesto 20 sin resultados satisfactorios. The Azo Route figure 4.1. It was used as the starting compound imidazole 9, the strategy presented by Gandolfi Donadío, L et al., Consists of introducing the nitrogen functionality by coupling between 9 and 8 to give the azoderivative 10. Then it presents the reduction of 10, to form an aminoimidazole derivative 15 in the presence of Pd (black) and formic acid. Oxidation via diazonium salt of 15 forms a mixture containing 2-chloroimidazole. According to the publication, derivatives 19 and 24 were synthesized in good yields and various reaction conditions were tested to obtain compound 20 without satisfactory results.

Además muestran otras dos rutas de obtención vía imidazolona (Figura 4.2) y vía 2-metil tioimidazol (Figura 4.3). Estas rutas plantean como última etapa de síntesis, la reacción entre /V-bencíl-2-cloroacetamida y 2-nitro-1 H-¡midazol en presencia de una base fuerte NaH y utilizando como disolvente DMF para obtener la molécula de benznidazol. They also show two other routes of obtaining via imidazolone (Figure 4.2) and via 2-methyl thioimidazole (Figure 4.3). These routes pose as the last stage of synthesis, the reaction between / V-benzyl-2-chloroacetamide and 2-nitro-1 H-midazole in the presence of a strong NaH base and using DMF as solvent to obtain the benznidazole molecule.

Las rutas descritas por Gandolfi Donadío, L et al., tanto, en la ruta imidazolona como en la ruta 2-metil-tio-imidazol los tres pasos finales de síntesis son pasos que se encuentran en vías de estudio, según la publicación. En general las rutas planteadas en Gandolfi Donadío, L et al presentan una serie de pasos que involucran varios reactivos y condiciones de calentamiento y la formación de varios productos intermediarios. La presente invención se lleva cabo haciendo reaccionar la N-beñcil-2-cloroacetamida con 2-nitroimidazol, utilizando como catalizador bromuro de tetrabutilamonio (TBAB) y carbonato de potasio (K2CO3). La reacción se lleva a cabo tanto en ausencia de disolvente como en presencia de agua y en ambas casos sin aplicar algún tipo de calentamiento. The routes described by Gandolfi Donadío, L et al., Both in the imidazolone route and in the 2-methyl-thio-imidazole route, the three final steps of synthesis are steps that are being studied, according to the publication. In general, the routes proposed in Gandolfi Donadío, L et al present a series of steps that involve various reagents and heating conditions and the formation of several intermediary products. The present invention is carried out by reacting N-beñyl-2-chloroacetamide with 2-nitroimidazole, using tetrabutylammonium bromide (TBAB) and potassium carbonate (K2CO3) as catalyst. The reaction is carried out both in the absence of solvent as in the presence of water and in both cases without applying any type of heating.

Hernandez-Nuñez, Emanuel et al. Synthesis and in vitro trichomonicidal, giardicidal and amebicidal activity of A/-acetamide(sulfonamide)-2-methyl-4-nitro- 1 H-imidazoles. European Journal of Medicinal Chemistry, 44 (2009) 2975-2984. Presenta una serie de a-cloroacetamidas sustituidas 16a y 16b-h, sintetizadas por condensación de cloruro de 2-qloroacetilo (18) con bencilamina (a) y anilinas 4- sustituidas (b-h), respectivamente, a través de dos metodologías, según la figura 5. En el primero, utilizan cloruro de metileno como disolvente y trietilamina como base. En el segundo, utilizan como disolvente acetona y bicarbonato de sodio como base. Hernandez-Nuñez, Emanuel et al. Synthesis and in vitro trichomonicidal, giardicidal and amebicidal activity of A / -acetamide (sulfonamide) -2-methyl-4-nitro- 1 H-imidazoles. European Journal of Medicinal Chemistry, 44 (2009) 2975-2984. It presents a series of substituted a-chloroacetamides 16a and 16b-h, synthesized by condensation of 2-chloroacetyl chloride (18) with benzylamine (a) and substituted 4- anilines (bh), respectively, through two methodologies, according to the Figure 5. In the first, they use methylene chloride as solvent and triethylamine as the base. In the second, they use acetone and sodium bicarbonate as the base as solvent.

Hernandez-Nuñez, Emanuel et al. Describen que mediante ja reacción de sustitución nucleofílica bimolecular obtienen una serie de derivados íniíidazolicos, /V-acetamida (sulfonamida)-2-methyl-4-nitroimidazoles, de estructura general (i) y (¡i) según figura 6. Hernandez-Nuñez, Emanuel et al. They describe that by means of the bimolecular nucleophilic substitution reaction they obtain a series of íniidazolic derivatives, / V-acetamide (sulfonamide) -2-methyl-4-nitroimidazoles, of general structure (i) and (i) according to figure 6.

Figure imgf000008_0001
Figura 6. Derivados imidazolicos obtenidos en Hernandez-Ñúñez, Emanuel et al.
Figure imgf000008_0001
Figure 6. Imidazolic derivatives obtained in Hernandez-Ñúñez, Emanuel et al.

Los derivados imidazólicos de fórmula general (i) fueron preparados a partir del anión 4(5)-nitro-2-metil-1 /-/-imidazol mediante una sustitución nucleofílica bimolecular, utilizando carbonato de potasio y acetonitrilo. El método general de síntesis se lleva a cabo con disolución de 4(5)-nitro-2-metil-1 /-/-imidazol e hidróxido de potasio, para generar el anión 4(5)-nitro-2-metil-1 H-imidazol en presencia de acetonitrilo. Esta disolución se agita durante 30 minutos y a esta mezcla se le añade a-cloroacetamida sustituida, disuelta en acetonitrilo. Se agita y se calienta a reflujo por 8 horas. El disolvente es removido al vacío y el residuo obtenido, es lavado con agua y posteriormente se recristaliza con un disolvente apropiado. Los derivados imidazólicos de fórmula general (i), fueron preparados vía reacción de copulación a partir del anión 4(5)-nitro-2-metil-1 /-/-imidazol con cloruros de arilsulfonilo, en presencia de hidróxido de potasio, 4-dimetilaminopiridina (catalizador) y trietilamina. Hernandéz-Núñez, Emanuel et al, presenta derivados sustituidos con grupo -NO2 en carbono 3 ó 4 y sustituyente metilo (-CH3) en carbono 2. La reacción con a- cloroacetamidas sustituidas se lleva a cabo en presencia ' de hidróxido de potasio, carbonato de potasio y acetonitrilo como disolvente, y con caléntamiento a reflujo. Las moléculas obtenidas son derivados homólogos al metronidazpl, que poseen un grupo nitro (-NO2) en posición 4 y un grupo metilo sustituido en carbono 2. Imidazole derivatives of the general formula (i) were prepared from anion 4 (5) -nitro-2-methyl-1 / - / - imidazole by a bimolecular nucleophilic substitution, using potassium carbonate and acetonitrile. The general method of synthesis is carried out with dissolution of 4 (5) -nitro-2-methyl-1 / - / - imidazole and potassium hydroxide, to generate anion 4 (5) -nitro-2-methyl-1 H-imidazole in the presence of acetonitrile. This solution is stirred for 30 minutes and to this mixture is added substituted a-chloroacetamide, dissolved in acetonitrile. It is stirred and heated at reflux for 8 hours. The solvent is removed in vacuo and the residue obtained is washed with water and subsequently recrystallized with an appropriate solvent. Imidazole derivatives of the general formula (i) were prepared via coupling reaction from anion 4 (5) -nitro-2-methyl-1 / - / - imidazole with arylsulfonyl chlorides, in the presence of potassium hydroxide, 4 -dimethylaminopyridine (catalyst) and triethylamine. Hernandez-Nunez, Emanuel et to the, has substituted derivatives -NO2 group 3 or 4 carbon substituent and methyl (-CH 3) carbon 2. Reaction with chloroacetamide substituted a- is carried out in the presence 'of potassium hydroxide , potassium carbonate and acetonitrile as solvent, and with reflux heating. The molecules obtained are derivatives homologous to metronidazpl, which have a nitro group (-NO2) in position 4 and a methyl group substituted on carbon 2.

La síntesis de nuestra invención a diferencia de la presentada por HERNANDÉZ- NÚÑEZ, EMANUEL et al., se lleva a cabo con 2-nitroimidázol, haciéndolo reaccionar con /\/-bencil-2-cloroacetamida en presencia únicamente de carbonato de potasio y bromuro de tetrabutilamonio como catalizador, en ausencia de disolvente orgánico y sin calentamiento. Mientras que Hernandéz-Núñez, Emanuel et al, presenta derivados sustituidos con grupo nitro (-N02) en carbono 3 ó 4 y sustituyente metilo (-CH3) en carbono 2. La reacción con a-cloroacetamidas sustituidas sé lleva a cabo en presencia de hidróxido de potasio, carbonato de potasio y acetonitrilo como disolvente, y con calentamiento a reflujo.The synthesis of our invention, unlike that presented by HERNANDÉZ-NÚÑEZ, EMANUEL et al., Is carried out with 2-nitroimidazole, reacting it with / \ / - benzyl-2-chloroacetamide in the presence of only potassium carbonate and bromide of tetrabutylammonium as catalyst, in the absence of organic solvent and without heating. While Hernandéz-Núñez, Emanuel et al, presents derivatives substituted with nitro group (-N0 2 ) in carbon 3 or 4 and methyl substituent (-CH 3 ) in carbon 2. The reaction with substituted a-chloroacetamides is carried out in presence of potassium hydroxide, potassium carbonate and acetonitrile as solvent, and with heating under reflux.

Figure imgf000009_0001
Figure imgf000009_0001

La patente US 9,765,036 B2 presenta un método de preparación de /V-bencil-2- (2-nitro- 1 H-imidazol-1 -il) acetamida utilizando como materiales ; iniciales N- bencil-1- hidroxiacetamida y 2-nitroimidazol en estado solido y en ausencia de disolvente. El procedimiento ocurre mezclando los dos materiales iniciales y activando mediante irradiación de microondas para formar la N- bencil-2- (2nitro-tH-imidazol-1-il) acetamida. La mezcla de reacción se purifica en una columna de cromatografía, usando como fase estacionaria alúmina y como fase móvil acetato de etilo: El método no requiere catalizadores ácidos o bases en el proceso de síntesis.US Patent 9,765,036 B2 presents a method of preparing / V-benzyl-2- (2-nitro-1 H-imidazol-1-yl) acetamide using as materials ; initials N-benzyl-1-hydroxyacetamide and 2-nitroimidazole in the solid state and in the absence of solvent. The procedure occurs by mixing the two initial materials and activating by microwave irradiation to form the N-benzyl-2- (2-nitro-tH-imidazol-1-yl) acetamide. The reaction mixture is purified on a chromatography column, using alumina as the stationary phase and ethyl acetate as the mobile phase: The method does not require acid catalysts or bases in the synthesis process.

Figure imgf000009_0002
Figure imgf000009_0002

La invención presentada en US 9,765,036 B2 se lleva a cabo con 2-nitroimidazol, haciéndolo reaccionar N-bencil-2-cloroacetamida en presencia de irradiación microondas, mientras que la presente no requiere de ningún tipo de caléntamiento y la ejecución del procedimiento se realiza en condiciones suaves de reacción y no requiere el uso de equipos sofisticados para su desarrollo.

Figure imgf000009_0003
The invention presented in US 9,765,036 B2 is carried out with 2-nitroimidazole, reacting N-benzyl-2-chloroacetamide in the presence of microwave irradiation, while the present does not require any type of heating and the procedure is carried out in Smooth reaction conditions and does not require the use of sophisticated equipment for its development.
Figure imgf000009_0003

Figure imgf000009_0004
Figure imgf000009_0004

La solicitud de patente WO 2017/205622 A1 presenta -un método para preparar benznidazol haciendo reaccionar 2-nitroimidazol (1 ,5 g) dé fórmula 1 en figura 7, carbonato de potasio (6,72 g) y bromo acetato de etilo (8,12 g, 5,;39 mL) de fórmula 2 en figura 7, se calientan a 70°C por 110 minutos, esta mezclare reacción es enfriada a 50°C y se adiciona bencilamina, la suspensión es agitada por 16 horas. Se adicione agua (50 mL), la masa de reacción es enfriada de 0 a 5°C y se agita por 2 horas, se filtra y se lava con 25 mL de agua fría. Se obtiene benznidazol de fórmula 3 en figura 7, como una pasta sólida. La pasta sólida es secada al vacío y a 50°C por 16 horas y el benznidazol de fórmula 3 en figura 7, es obtenido como un sólido amarillo pálido, 10.01 g (87%). El benznidazol fórmula 3 en figura 7, es recristálizado con una mezcla de acetona: metanol: agua (49.9 mL, 49.9 mL, 5.3 mL). Patent application WO 2017/205622 A1 presents a method for preparing benznidazole by reacting 2-nitroimidazole (1.5 g) of formula 1 in figure 7, potassium carbonate (6.72 g) and bromine ethyl acetate (8 , 12 g, 5; 39 mL) of formula 2 in Figure 7, heated at 70 ° C for 110 minutes, this reaction mixture is cooled to 50 ° C and benzylamine is added, the suspension is stirred for 16 hours. Water (50 mL) is added, the reaction mass is cooled from 0 to 5 ° C and stirred for 2 hours, filtered and wash with 25 mL of cold water. Benznidazole of formula 3 in Figure 7 is obtained as a solid paste. The solid paste is dried under vacuum and at 50 ° C for 16 hours and the benznidazole of formula 3 in figure 7 is obtained as a pale yellow solid, 10.01 g (87%). The benznidazole formula 3 in figure 7 is recrystallized with a mixture of acetone: methanol: water (49.9 mL, 49.9 mL, 5.3 mL).

2 two

Figure imgf000010_0002
Figure imgf000010_0002

En la solicitud de patente WO 2017/205622 A1 se prepara benznidazol a partir de 2- nitroimidazol y éster haluro de acetato, donde el haluro puede ser bromo, yodo y cloro donde el R (del grupo alcóxido) puede ser metilo, etilo, isoprópilo, neobutilo, ¡sobutilo y terbutilo, preferentemente utilizan como éster bromoacetato de etilo, realizando la reacción en presencia de carbonato de potasio, mediante Una serie de pasos que requieren de calentamiento y enfriamiento. Obteniéndose el benznidazol en forma de una pasta sólida que requiere posterior proceso de recristalización. Mientras que esta invención se realiza a partir de 2-nitroimidazole y /V-bencil-2-cloroacetamida, no requiere de calentamiento o enfriamiento, el benznidazol se obtiene de forma de un sólido que facilita el proceso de lavado para obtener el producto con alta pureza.In patent application WO 2017/205622 A1 benznidazole is prepared from 2- nitroimidazole and acetate halide ester, where the halide can be bromine, iodine and chlorine where R (of the alkoxide group) can be methyl, ethyl, isopropyl , neobutyl, butyl and terbutyl, preferably use ethyl bromoacetate as the ester, carrying out the reaction in the presence of potassium carbonate, by means of a series of steps that require heating and cooling. Obtaining benznidazole in the form of a solid paste that requires subsequent recrystallization process. While this invention is made from 2-nitroimidazole and / V-benzyl-2-chloroacetamide, does not require heating or cooling, benznidazole is obtained in the form of a solid that facilitates the washing process to obtain the product with high purity.

Figure imgf000010_0001
Figure imgf000010_0001

Descripción de la invención.  Description of the invention

La presente invención trata de un método de síntesiá para la obtención de Benznidazol ó /V-bencil-2-(2-nitro-1 H-imidazol-1-il)acefam¡da de fórmula (I), de elevada pureza,

Figure imgf000011_0001
The present invention deals with a method of synthesis for the production of Benznidazole or / V-benzyl-2- (2-nitro-1 H-imidazol-1-yl) acephalamide of formula (I), of high purity,
Figure imgf000011_0001

mediante la reacción de 2-nitroimidazol de fórmula (II) con /V-bericil-2-cloroacetamida de fórmula (III), a temperatura ambiente en un rango de 20 a 35°C, llevado a cabo en un tiempo de hasta 72 horas, en presencia de una base y de catalizador. Se desarrollaron dos vías de síntesis: una en ausencia de disolvente, y otra eri presencia de disolvente. by reacting 2-nitroimidazole of formula (II) with / V-bericyl-2-chloroacetamide of formula (III), at room temperature in a range of 20 to 35 ° C, carried out in a time of up to 72 hours , in the presence of a base and catalyst. Two synthetic routes were developed: one in the absence of solvent, and another in the presence of solvent.

Figure imgf000011_0002
Figure imgf000011_0002

Es un método de síntesis realizado mediante el uso de una, base como carbonato de potasio (K2CO3), y como catalizador bromuro de tetrabutilamonió (TBAB). La relación molar de la molécula de fórmula (II) y carbonato de. potasio (K2GQ3) es desde uno a uno hasta uno a seis, respectivamente. Es un método de síntesis, es llevado a cabo mezclando los compuestos de fórmulas (II) y (III), utilizando: relaciones molares desde uno a uno hasta uno a uno punto cinco para las moléculas orgánicas, agregando carbonato de potasio, y luego bromuro de tetrabutilamonió, ü a vía es realizada en ausencia de disolvente. Se ensayaron varios ordenes de adición para realizar la síntesis: mezclando los compuestos de fórmulas (II) y (III), agregando bromuro de tetrabutilamonió y luego carbonato de potasio, llevado a cabo, en ausencia de disolvente. También se ensayo mezclando los compuestos de fórmulas (II) y (III), agregando carbonato de potasio, y luego bromuro de tetrabutilamonió, llevado a cabo en ausencia de disolvente. Asimismo la reacción es realizada mezclandp .e! compuesto de fórmula (II) con carbonato de potasio, agregando a esta mezcla el compuesto de fórmula (III), y posteriormente bromuro de tetrabutilamonió, llevado a cabo ¾n ausencia de disolvente. It is a synthesis method carried out by using a base such as potassium carbonate (K 2 CO 3 ), and as a tetrabutylammonium bromide (TBAB) catalyst. The molar ratio of the molecule of formula (II) and carbonate of. Potassium (K 2 GQ 3 ) is from one to one to one to six, respectively. It is a synthesis method, it is carried out by mixing the compounds of formulas (II) and (III), using: molar ratios from one to one to one to one point five for the organic molecules, adding potassium carbonate, and then bromide of tetrabutylammonium, the route is performed in the absence of solvent. Several addition orders were tested to perform the synthesis: mixing the compounds of formulas (II) and (III), adding tetrabutylammonium bromide and then potassium carbonate, carried out , in the absence of solvent. It was also tested by mixing the compounds of formulas (II) and (III), adding potassium carbonate, and then tetrabutylammonium bromide, carried out in the absence of solvent. Also the reaction is carried out mixing .e! compound of formula (II) with potassium carbonate, adding to this mixture the compound of formula (III), and then tetrabutylammonium bromide, carried out in the absence of solvent.

La segunda vía de reacción consistió en realizar la síntesis en presencia de disolvente, haciendo reaccionar 2-nitroimidazol de fórmula (II) con /V-benCil-2-cloroacetamida de fórmula (III), seguida de la adición de carbonato de potasio y bromuro de tetrabutilamonio, posteriormente adicionando agua para obtepér mezcla de reacción homogénea. The second reaction route consisted of carrying out the synthesis in the presence of solvent, reacting 2-nitroimidazole of formula (II) with / V-benCyl-2-chloroacetamide of formula (III), followed by the addition of potassium carbonate and tetrabutylammonium bromide, subsequently adding water to obtain a homogeneous reaction mixture.

Otro procedimiento consistió en realizar la reacción disolviendo carbonato de potasio en agua, adicionando el compuesto de fórmula (II) y posterior. adición del compuesto de fórmula (III) y bromuro de tetrabutilamonio. Los métodos de síntesis descritos permiten obtener benznidazol de elevada pureza; además permite la reutilización de las aguas madres del proceso de síntesis, para obtener más benznidazol siempre de elevada pureza. Nuestro método tiene comprobación de escalado, se ha trabajado en reacciones empleando hasta una masa de 2-nitroimidazol superior a 2Ó0 gramos. Las síntesis a mayor escala se han realizado en el laboratorio de Química Fina del Instituto Polo Científico de Pando (IPCP), Uruguay.

Figure imgf000012_0001
Another procedure was to carry out the reaction by dissolving potassium carbonate in water, adding the compound of formula (II) and later. addition of the compound of formula (III) and tetrabutylammonium bromide. The synthesis methods described allow benznidazole of high purity to be obtained; It also allows the reuse of the mother liquor of the synthesis process, to obtain more benznidazole always of high purity. Our method has scaling check, we have worked on reactions using up to a mass of 2-nitroimidazole greater than 20 grams. The larger-scale syntheses have been carried out in the Fine Chemistry laboratory of the Pando Polo Scientific Institute (IPCP), Uruguay.
Figure imgf000012_0001

Las aguas madres obtenidas de la síntesis, se han reutilizado para llevar a cabo otro proceso de la misma síntesis, en algunos casos adicionando únicamente, 2-nitroimidazo y A/-bencil-2-cloroacetamida. Cuando la relación molar de 2rhitroimidazol y carbonato de potasio es de mol a mol, el segundo sido de reacción requiere adición de carbonato de potasio. Obteniéndose benznidazol de alta pureza.  The mother liquor obtained from the synthesis has been reused to carry out another process of the same synthesis, in some cases adding only 2-nitroimidazo and A / -benzyl-2-chloroacetamide. When the molar ratio of 2rhithroimidazole and potassium carbonate is from mole to mole, the second reaction state requires the addition of potassium carbonate. Obtaining high purity benznidazole.

Ejemplo de ejecución 1 Execution Example 1

Esta reacción se realiza de la siguiente manera: Se mezclan 2-nitroimidazol (1.0 g, 8.8 x 103 moles) conl/V-bencil-2-cloroacetamida (1.7864 g, 9.7 x 103 moles), en ausencia de disolvente. Cuando la mezcla se homogeniza, se adiciona bromuro de tetrabutilamonio (2.85 0 g, 8.8 x 10^ moles), se continúa mezclando y posteriormente se adiciona carbonato- de potasio, (4.8892 g, 3.5 x 10’2 moles). La mezcla de reacción se deja en reposo hasta 72 horas. El producto de síntesis es aislado mediante la realización de lavados con agua hasta pH neutro. Al benznidazol obtenido, se le realizó análisis por TLC, cromatografía líquida de alta resolución con detector de arreglo de fotodiodo (Figura 1 de anexos), correspondiendo con el tiempo de retención con patrón de referencia, cromatografía de gases acoplada a espectrometría de masas correspondiendo el tiempo de retención en el cromatograma y el espectro de masas con el patrón de referencia, se realizó espectroscopia infrarroja presentando señales de su espectro que coinciden con las señales del patrón de referencia. This reaction is carried out as follows: 2-Nitroimidazole (1.0 g, 8.8 x 10 3 moles) is mixed with 1 / V-benzyl-2-chloroacetamide (1,764 g, 9.7 x 10 3 moles), in the absence of solvent. When the mixture is homogenized, tetrabutylammonium bromide (2.85 g 0, 8.8 x 10 ^ moles), is added and mixing is continued subsequently added carbonate- potassium (4.8892 g, 3.5 x 10 '2 moles). The reaction mixture is allowed to stand up to 72 hours. The synthesis product is isolated by performing water washes to neutral pH. To the The obtained benznidazole was performed by TLC analysis, high performance liquid chromatography with photodiode array detector (Figure 1 of annexes), corresponding to the retention time with reference standard, gas chromatography coupled to mass spectrometry corresponding time Withholding in the chromatogram and the mass spectrum with the reference standard, infrared spectroscopy was performed presenting signals of its spectrum that coincide with the signals of the reference standard.

Ejemplo de ejecución 2. Execution example 2.

Esta reacción se realiza de la siguiente manera: This reaction is carried out as follows:

Se mezclan 2-nitroimidazol (1.0 g, 8.8 x 103 moles) con /V-bencil-2-cloroacetamida (1.7864 g, 9.7 x 103 moles) en ausencia de disolvente. Guando la mezcla se homogeniza, se adiciona carbonato de potasio, K2CO3, (4.8892 g, 3.5 x 10'2 moles), se continúa mezclando, posteriormente se agrega el bromuro de tetrabutilamonio (2.8510 g, 8.8 x 10'3 moles). La mezcla de reacción se deja en reposo hasta 72 horas. El producto de síntesis es aislado mediante la realización de lavados con agua hasta pH neutro. Al benznidazol obtenido, se le realizó análisis por TLC, crórtiatografía líquida de alta resolución con detector de arreglo de fotodiodo (Figura 2 de an xos), correspondiendo con el tiempo de retención con patrón de referencia, cromatografía de gases acoplada a espectrometría de masas correspondiendo el tiempo de retención en el cromatograma y el espectro de masas con el patrón de referencia, se realizó espectroscopia infrarroja presentando señales de su espectro que coinciden con las señales del patrón de referencia. 2-Nitroimidazole (1.0 g, 8.8 x 10 3 moles) is mixed with / V-benzyl-2-chloroacetamide (1,764 g, 9.7 x 10 3 moles) in the absence of solvent. Guando the mixture is homogenized, potassium carbonate, K2CO3 (4.8892 g, 3.5 x 10 is added '2 moles), mixing is continued subsequently tetrabutylammonium bromide (2.8510 g, 8.8 x 10 adds' 3 moles). The reaction mixture is allowed to stand up to 72 hours. The synthesis product is isolated by performing water washes to neutral pH. The benznidazole obtained was analyzed by TLC, high resolution liquid cryography with photodiode array detector (Figure 2 of years), corresponding to the retention time with reference standard, gas chromatography coupled to mass spectrometry corresponding the retention time in the chromatogram and the mass spectrum with the reference pattern, infrared spectroscopy was performed presenting signals of its spectrum that coincide with the signals of the reference pattern.

Ejemplo de ejecución 3. Execution example 3.

Esta reacción se realiza de la siguiente manera: This reaction is carried out as follows:

Se mezclan 2-nitroimidazol (5.0 g, 4.4 x 10-2 moles) con . /y-bencil-2-cloroacetamida (8.932 g, 4.8 x 10'2 moles) en ausencia de disolvente. Cuando la mezcla se homogeniza, se adiciona carbonato de potasio (24.446 g, 1.7 x 10'1 moles), se continúa mezclando, posteriormente se agrega el bromuro de tetrabutilamonio (14.225 g, 4.4.x 10_1 moles). La mezcla de reacción se deja en reposo hasta 72 horas. É| producto de síntesis es aislado mediante la realización de lavados con agua hasta pH< neutro. Al benznidazol obtenido, se le realizo análisis por TLC, cromatografía líquida de alta resolución con detector de arreglo de fotodiodo, correspondiendo con el tiempo de retención con patrón de referencia, cromatografía de gases acoplada a espectrometría de masas correspondiendo el tiempo de retención en el cromatograma se realizó espectroscopia infrarroja presentando señales de su espectro que coinciden ' con las señales del patrón de referencia. Ejemplo de ejecución 4. 2-Nitroimidazole (5.0 g, 4.4 x 10 -2 moles) is mixed with. / y-benzyl-2-chloroacetamide (8.932 g, 4.8 x 10 '2 moles) in absence of solvent. When the mixture is homogenized, potassium carbonate (24,446 g, 1.7 x 10 '1 mol) is added continuously mixing it subsequently tetrabutylammonium bromide (14.225 g, 4.4.x 10 _1 moles) is added. The reaction mixture is allowed to stand up to 72 hours. É | Synthesis product is isolated by performing water washings until pH < neutral. The benznidazole obtained was analyzed by TLC, high performance liquid chromatography with photodiode array detector, corresponding to the retention time with standard of reference, gas chromatography coupled to mass spectrometry corresponding retention time in the chromatogram was performed infrared spectroscopy spectrum showing signals matching 'with the signal reference pattern. Execution example 4.

Esta reacción se realiza de la siguiente manera: This reaction is carried out as follows:

En presencia de agitación magnética, se adiciona 2-nitroimidazol (5.0 g, 4.4 x 102 moles) a un recipiente que contiene agua, luego se adiciona carbonato de potasio (24.446 g, 1.7 x 10 1 moles) se continua mezclando hasta formar una mezcla homogénea, posteriormente se adiciona /\/-bencil-2-cloroacétámida (8.932 g, 4.8 x 102 moles). Finalmente se agrega el bromuro de tetrabutilamonio ( 4.225 g, 4.4 x 10 1 moles). La mezcla de reacción se continúa agitando hasta 72 horas. El producto de síntesis es aislado mediante la realización de lavados con agua hasta pH neutro. Al benznidazol obtenido, se le realizo análisis por TLC, cromatografía líquida de alta resolución con detector de arreglo de fotodiodo (Figura 3 de anexos), correspondiendo con el tiempo de retención con patrón de referencia, cromatografía de gases acoplada a espectrometría de masas correspondiendo el tiempo de retención en el cromatograma y el espectro de masas con el patrón de referencia, se realizó espectroscopia infrarroja presentando señales de su espectro que coinciden con las señales del patrón de referencia. In the presence of magnetic stirring, 2-nitroimidazole (5.0 g, 4.4 x 10 2 moles) is added to a container containing water, then potassium carbonate (24,446 g, 1.7 x 10 1 moles) is added, mixing is continued until it forms a Homogeneous mixture, then / / / - benzyl-2-chloroacetamide (8,932 g, 4.8 x 10 2 moles) is added. Finally, tetrabutylammonium bromide (4.225 g, 4.4 x 10 1 mol) is added. The reaction mixture is continued stirring up to 72 hours. The synthesis product is isolated by performing water washes to neutral pH. The benznidazole obtained was analyzed by TLC, high performance liquid chromatography with photodiode array detector (Figure 3 of annexes), corresponding to the retention time with reference standard, gas chromatography coupled to mass spectrometry corresponding to retention time in the chromatogram and the mass spectrum with the reference pattern, infrared spectroscopy was performed presenting signals of its spectrum that coincide with the signals of the reference pattern.

Ejemplo de ejecución 5. Execution example 5.

Esta reacción se realiza de la siguiente manera: This reaction is carried out as follows:

Se mezclan 2-nitroimidazol (10.0 g, 8.8 x 102 moles), A/-benóil-2-clóroacetamida (17.864 g, 9.7 x 102 moles), bromuro de tetrabutilamonio (28.45 g, 8;8 x -10-1 moles), carbonato de potasio (48.892 g, 0.35 moles) y luego se adiciona agua formando una mezcla homogénea. La mezcla de reacción se mantiene con agitáción magnética hasta 72 horas. El producto de síntesis es aislado mediante la realización de lavados con agua hasta pH neutro. Al benznidazol obtenido, se le realizo análisis por TLC, cromatografía líquida de alta resolución con detector de arreglo de fotodiodo(Figura 4 de anexos), correspondiendo con el tiempo de retención con patrón de referencia, cromatografía de gases acoplada a espectrometría de masas correspondiendo el tiempo de retención en el cromatograma y el espectro de masas con el patrón de referencia, se realizó 8 x -10- 1, 2-nitroimidazole (10.0 g, 8.8 × 10 2 moles), A / 2-chloroacetamide -benóil-(17.864 g, 9.7 × 10 2 mol), tetrabutylammonium bromide (28.45 g, 8 are mixed moles), potassium carbonate (48,892 g, 0.35 moles) and then water is added forming a homogeneous mixture. The reaction mixture is maintained with magnetic stirring for up to 72 hours. The synthesis product is isolated by performing water washes to neutral pH. To the obtained benznidazole, TLC analysis, high resolution liquid chromatography with photodiode array detector (Figure 4 of annexes) were performed, corresponding to the retention time with reference standard, gas chromatography coupled to mass spectrometry corresponding to retention time on the chromatogram and mass spectrum with the reference standard, was performed

13 espectroscopia infrarroja presentando señales de su espectro que coinciden con las señales del patrón de referencia. 13 Infrared spectroscopy presenting signals of its spectrum that coincide with the signals of the reference standard.

Ejemplo de ejecución 6. Execution example 6.

Esta reacción se realiza de la siguiente manera: En presencia de agitación, se disuelve en agua carbonato de potasio (12.2219 g, 8.8 x 10 2 moles), luego se adiciona el 2-nitroimidazol (5.0 g, 4.4 x ID 2 moles) hasta disolución completa posteriormente se adiciona A/-benc¡l-2-doroacetám¡da (8.932 g, 4.8 x 102 moles) se continua agitando hasta mezcla homogénea. Finalmente se agrega el bromuro de tetrabutilamonio (14.225 g, 4.4 x 10 1 moles) La mezcla de reacción se continúa agitando hasta 72 horas. El producto de síntesis es aislado mediante la realización de lavados con agua hasta pH neutro. Al benznidazol obtenido, se le realizo análisis por TLC, cromatografía líquida de alta resolución con detector de arreglo de fotodiodo (Figura 5 de anexos), correspondiendo con el tiempo de retención con patrón de referencia, cromatografía de gases acoplada a éspectrometría de masas correspondiendo el tiempo de retención en el cromatograrria se realizó espectroscopia infrarroja presentando señales de su espectro que coinciden con las señales del patrón de referencia. This reaction is carried out as follows: In the presence of agitation, potassium carbonate (12.2219 g, 8.8 x 10 2 moles) is dissolved in water, then 2-nitroimidazole (5.0 g, 4.4 x ID 2 moles) is added until Complete solution is subsequently added A / -benzyl-2-doroacetamide (8,932 g, 4.8 x 10 2 moles), stirring is continued until homogeneous mixing. Finally, tetrabutylammonium bromide (14,225 g, 4.4 x 10 1 mol) is added. The reaction mixture is stirred for up to 72 hours. The synthesis product is isolated by performing water washes to neutral pH. To the obtained benznidazole, TLC analysis, high resolution liquid chromatography with photodiode array detector (Figure 5 of annexes) were performed, corresponding to the retention time with reference standard, gas chromatography coupled to mass spectrometry corresponding to Chromatography retention time was performed infrared spectroscopy presenting signals of its spectrum that coincide with the signals of the reference standard.

Ejemplo de ejecución 7. Execution example 7.

Esta reacción se realiza de la siguiente manera: En presencia de agitación, se disuelve en agua carbonato dé potasio (6.1110 g, 4.4 x 10 2 moles), luego se adiciona el 2-nitroimidazol (5.0 g, 4.4 x 10:? moles) hasta disolución completa posteriormente se adiciona N-bendl-2-cloroacetamida (8.932 g, 4.8 x 102 moles) se continua agitando hasta mezcla homogénea. Finalmente se agrega el bromuro de tetrabutilamonio (14.225 g, 4.4 x 10:1 moles). .La mezcla de reacción se continúa agitando hasta 72 horas. El producto de síntesis' es. aislado mediante la realización de lavados con agua hasta pH neutro. Al benznidazol obtenido, se le realizo análisis por TLC, cromatografía líquida de alta resolución con detector de arreglo de fotodiodo (Figura 6 de anexos), correspondiendo con el tiempo de retención con patrón de referencia, cromatografía de gases acoplada a éspectrometría de masas correspondiendo el tiempo de retención en el cromatograma se realizó espectroscopia infrarroja presentando señales de su espectro que coinciden con las señales del patrón de referencia. Ejemplo de ejecución 8. This reaction is carried out as follows: In the presence of agitation, it is dissolved in potassium carbonate water (6.1110 g, 4.4 x 10 2 moles), then 2-nitroimidazole (5.0 g, 4.4 x 10 :? Moles) is added until complete dissolution, N-bendl-2-chloroacetamide (8,932 g, 4.8 x 10 2 moles) is added until stirring is continued until homogeneous mixing. Finally, tetrabutylammonium bromide (14,225 g, 4.4 x 10: 1 mol) is added. The reaction mixture is continued stirring up to 72 hours. The synthesis product ' is. isolated by performing water washes to neutral pH. To the obtained benznidazole, TLC analysis, high resolution liquid chromatography with photodiode array detector (Figure 6 of annexes) were performed, corresponding to the retention time with reference standard, gas chromatography coupled to mass spectrometry corresponding to Chromatogram retention time was performed infrared spectroscopy presenting signals of its spectrum that match the signals of the reference standard. Execution example 8.

Esta reacción se realizó en el laboratorio de Química Fina del Instituto Polo Científico de Pando (IPCP), Uruguay y se lleva a cabo de la siguiente manera: This reaction was carried out in the Fine Chemistry laboratory of the Pando Polo Scientific Institute (IPCP), Uruguay and is carried out as follows:

En presencia de agitación mecánica, se disuelve en agua carbonato de potasio (431.21 g; 3,12 moles), posteriormente se adiciona el 2-nitroimidazol (88.23g; 0.78 moles), hasta disolución completa. Seguidamente se agrega /V-benc¡l-2-cloroacetamida (157.50g; 0.86 moles) hasta homogeneidad. Finalmente se agrega bromuro de tetrabutilamonio (251 ,47; 0.78 moles). La mezcla de reacción se continúa agitando hasta 72 horas. El producto de síntesis es aislado mediante la realización de lavados. con agua hasta pH neutro. Al benznidazol obtenido, se le realizo análisis por TLC, cromatografía líquida de alta resolución con detector de arreglo de fotodiodo > (Figura 7 de anexos), correspondiendo con el tiempo de retención con patrón de referencia, cromatografía de gases acoplada a espectrometría de masas correspondiendo el tiempo de retención en el cromatograma y el espectro de masas con el patrón de referencia, se realizó espectroscopia infrarroja presentando señales de su espectro ..que coinciden con las señales del patrón de referencia. In the presence of mechanical stirring, potassium carbonate (431.21 g; 3.12 moles) is dissolved in water, then 2-nitroimidazole (88.23g; 0.78 moles) is added, until completely dissolved. Then / V-benzyl-2-chloroacetamide (157.50g; 0.86 mol) is added until homogeneous. Finally, tetrabutylammonium bromide (251, 47; 0.78 moles) is added. The reaction mixture is continued stirring up to 72 hours. The synthesis product is isolated by performing washings. with water to neutral pH. To the obtained benznidazole, TLC analysis, high resolution liquid chromatography with photodiode array detector> (Figure 7 of annexes) were performed, corresponding to the retention time with reference standard, gas chromatography coupled to mass spectrometry corresponding the retention time in the chromatogram and the mass spectrum with the reference pattern, infrared spectroscopy was performed presenting signals of its spectrum .. that coincide with the signals of the reference pattern.

Ejemplo de ejecución 9. Execution example 9.

Esta reacción se realizó en el laboratorio de Química Fina del instituto Polo Científico de Pando (IPCP), Uruguay y se lleva a cabo de la siguiente mañera: This reaction was carried out in the Fine Chemistry laboratory of the Pando Polo Scientific Institute (IPCP), Uruguay and is carried out as follows:

En presencia de agitación mecánica, se disuelve en agua carbonato de potasio (1186,3 g; 8,58 moles), posteriormente se adiciona el 2-nitroimidazol (242.6 g;.2, 14 moles), hasta disolución completa. Seguidamente se agrega A/-bencil-2-cloroacetamida (431.80 g; 2.35 moles) hasta homogeneidad. Finalmente se agrega bromuro de tetrabutilamonio (691.4 g; 2.14 moles). La mezcla de reacción se continúa agitando hasta 72 horas. El producto de síntesis es aislado mediante la realización de lavados con agua hasta pH neutro. Al benznidazol obtenido, se le realizo análisis por TLC, cromatografía líquida de alta resolución con detector de arreglo de fotodiodoV (Figura 8 de anexos), correspondiendo con el tiempo de retención con patrón de referencia, cromatografía de gases acoplada a espectrometría de masas correspondiendo.' el tiempo de retención en el cromatograma y el espectro de masas con el patrón de referencia, se realizó espectroscopia infrarroja presentando señales de su espectro que coinciden con las señales del patrón de referencia. Ejemplo de ejecución 10. In the presence of mechanical agitation, potassium carbonate (1186.3 g; 8.58 moles) is dissolved in water, then 2-nitroimidazole (242.6 g; .2, 14 moles) is added, until completely dissolved. Then A / -benzyl-2-chloroacetamide (431.80 g; 2.35 moles) is added until homogeneous. Finally, tetrabutylammonium bromide (691.4 g; 2.14 moles) is added. The reaction mixture is continued stirring up to 72 hours. The synthesis product is isolated by performing water washes to neutral pH. The benznidazole obtained was analyzed by TLC, high performance liquid chromatography with photodiode array detector V (Figure 8 of annexes), corresponding to the retention time with reference standard, gas chromatography coupled to corresponding mass spectrometry. ' the retention time in the chromatogram and the mass spectrum with the reference pattern, infrared spectroscopy was performed presenting signals of its spectrum that coincide with the signals of the reference pattern. Execution example 10.

Utilizando 25 mL de aguas madres de reacción de ejemplo :de: ejecución 8, se hacen reaccionar 1 gramo de 2-nitroimidazol con 1.78 gramos de '/V-bencil-2-cloroacetamida la mezcla de reacción se agita durante 72 horas a temperatura ambiente. El sólido formado se separa de la disolución por destilación al vacio haciendo varios lavados con agua hasta alcanzar pH neutro en los lavados. El producto obtenido se analizó por cromatografía líquida de alta resolución con detector de arreglo de fotodíodo (Figura 9 de anexos), correspondiendo con el tiempo de retención con patrón de referencia de benznidazol. El producto obtenido posee elevada pureza según los análisis de HPLC realizados. Using 25 mL of example reaction mother liquors : from: run 8, 1 gram of 2-nitroimidazole is reacted with 1.78 grams of '/ V-benzyl-2-chloroacetamide the reaction mixture is stirred for 72 hours at room temperature . The solid formed is separated from the solution by vacuum distillation by doing several washings with water until neutral pH is reached in the washings. The product obtained was analyzed by high performance liquid chromatography with photodiod array detector (Figure 9 of annexes), corresponding to the retention time with benznidazole reference standard. The product obtained has high purity according to the HPLC analyzes performed.

Ejemplo de ejecución 11. Execution example 11.

Utilizando 50 mL de aguas madres de reacción de ejemplo! de ejecución 7, se hacen reaccionar 2.5 gramos de 2-nitroimidazol con 4.4612 gramps de /V-bencil-2- cloroacetamida, la mezcla de reacción se agita durante 72; horas a temperatura ambiente. El sólido formado se separa de la disolución por destilación al vacío haciendo varios lavados con agua hasta alcanzar pH neutro en los lavádós. El producto obtenido se analizó por cromatografía líquida de alta resolución con detector de arreglo de fotodiodo (Figura 10 de anexos), correspondiendo con el tiempo dé retención con patrón de referencia de benznidazol. El producto obtenido posee alta pureza según el análisis de HPLC realizados. Using 50 mL of sample reaction mother liquors! of execution 7, 2.5 grams of 2-nitroimidazole are reacted with 4,412 grams of / V-benzyl-2-chloroacetamide, the reaction mixture is stirred for 72; hours at room temperature. The solid formed is separated from the solution by vacuum distillation by doing several washings with water until neutral pH is reached in the washings. The product obtained was analyzed by high performance liquid chromatography with photodiode array detector (Figure 10 of annexes), corresponding to the retention time with benznidazole reference standard. The product obtained has high purity according to the HPLC analysis performed.

Claims

Reivindicaciones. Claims 1 ) Un método de síntesis para la obtención de Benznidazol ó A/-bencil-2-(2-nitro-1 H- ¡midazol-1-il)acetamida de fórmula (I), de elevada pureza, 1) A synthesis method for obtaining Benznidazole or A / -benzyl-2- (2-nitro-1 H- midazol-1-yl) acetamide of formula (I), of high purity,
Figure imgf000018_0001
caracterizado por hacer reaccionar 2-nitroimidazol de fórmula (II) con /V-bencil-2- cloroacetamida de fórmula (III), en ausencia de disolvente, á temperatura ambiente en un rango de 20 a 35°C, llevado a cabo en un tiempo de hasta 72 horas, en presencia de una base y de catalizador.
Figure imgf000018_0001
characterized by reacting 2-nitroimidazole of formula (II) with / V-benzyl-2-chloroacetamide of formula (III), in the absence of solvent, at room temperature in a range of 20 to 35 ° C, carried out in a time of up to 72 hours, in the presence of a base and catalyst.
Figure imgf000018_0002
Figure imgf000018_0002
(II) (III) 2) Un método de síntesis según la reivindicación 1 , caracterizado por utilizar como base carbonato de potasio (K2CO3). (II) (III) 2) A synthesis method according to claim 1, characterized in that potassium carbonate (K 2 CO 3) is used as the base. 3) Un método de síntesis según la reivindicación 1 , caracterizado por utilizar como catalizador bromuro de tetrabutilamonio (TBAB). 3) A synthesis method according to claim 1, characterized in that tetrabutylammonium bromide (TBAB) is used as catalyst. 4) Un método según la reivindicación 1 , caracterizado por utilizar relaciones molares desde uno a uno hasta uno a uno punto cinco para moléculas orgánicas de fórmulas4) A method according to claim 1, characterized by using molar ratios from one to one to one to one point five for organic molecules of formulas (II) y (III) respectivamente. (II) and (III) respectively. 5) Un método de síntesis según la reivindicación 1 , caracterizado por realizar la reacción en relación molar de compuesto de fórmula (II) y carbonato de potasio (K2CO3) desde uno a uno hasta uno a seis respectivamente. 6) Un método de síntesis según la reivindicación 1 , caracterizado por realizar la reacción en relación molar de compuesto de fórmula (II) y bromuro de tetrabutilamonio (TBAB). de uno a uno cada compuesto.; 7) Un método de síntesis según la reivindicación 1 , caracterizado por realizar la reacción mezclando los compuestos de fórmulas (II) y (III), agregando bromuro de tetrabutilamonio y luego carbonato de potasio, llevador a cabo en ausencia de disolvente. 5) A synthesis method according to claim 1, characterized by carrying out the reaction in molar ratio of compound of formula (II) and potassium carbonate (K2CO 3 ) from one to one to one to six respectively. 6) A synthesis method according to claim 1, characterized by carrying out the reaction in molar ratio of compound of formula (II) and tetrabutylammonium bromide (TBAB). one to one each compound .; 7) A synthesis method according to claim 1, characterized by carrying out the reaction by mixing the compounds of formulas (II) and (III), adding tetrabutylammonium bromide and then potassium carbonate, carried out in the absence of solvent. 8) Un método de síntesis según la reivindicación 1 , caracterizado por realizar la reacción mezclando los compuestos de fórmulas (II) y (lllj, agregando carbonato de potasio, y luego bromuro de tetrabutilamonio, llevado a cabo en ausencia de disolvente. 8) A synthesis method according to claim 1, characterized in that the reaction is carried out by mixing the compounds of formulas (II) and (lllj, adding potassium carbonate, and then tetrabutylammonium bromide, carried out in the absence of solvent. 9) Un método de síntesis según la reivindicación 1 , caracterizado por realizar la reacción mezclando el compuesto de fórmula (II) con carbonato de potasio, agregando a esta mezcla el compuesto de fórmula (III), y posteriormente bromuro de tetrabutilamonio, llevado a cabo en ausencia de disolvente. 9) A synthesis method according to claim 1, characterized in that the reaction is carried out by mixing the compound of formula (II) with potassium carbonate, adding to this mixture the compound of formula (III), and subsequently tetrabutylammonium bromide, carried out in the absence of solvent. 10) Un método de síntesis para la obtención de Benznidazol ó A/-bencil-2-(2-nitro-1 H- imidazo!-1-il)acetamida de fórmula (I), de elevada pureza,. 10) A synthesis method for obtaining Benznidazole or A / -benzyl-2- (2-nitro-1 H- imidazo! -1-yl) acetamide of formula (I), of high purity.
Figure imgf000019_0001
caracterizado por hacer reaccionar 2-nitroimidazol de fórmula (II) con N- bencil-2- clóroacetamida de fórmula (III), en presencia de disolvente a temperatura ambiente en un rango de 20 a 35°C, llevado a cabo con agitación, en un tiempo de hasta un máximo de 72 horas, en presencia de una base y de catalizador.
Figure imgf000019_0001
characterized by reacting 2-nitroimidazole of formula (II) with N-benzyl-2-chloroacetamide of formula (III), in the presence of solvent at room temperature in a range of 20 to 35 ° C, carried out with stirring, in a time of up to a maximum of 72 hours, in the presence of a base and catalyst.
Figure imgf000019_0002
Figure imgf000019_0002
11 ) Un método de síntesis según la reivindicación 10, caracterizado por utilizar como base carbonato de potasio (K2CO3). 12) Un método de síntesis según la reivindicación 10, caracterizado por utilizar como catalizador bromuro de tetrabutilamonio (TBAB). 11) A synthesis method according to claim 10, characterized in that potassium carbonate (K2CO3) is used as the base. 12) A synthesis method according to claim 10, characterized in that tetrabutylammonium bromide (TBAB) is used as catalyst. 13) Un método de síntesis según la reivindicación 10, caracterizado por utilizar como disolvente agua. 14) Un método según la reivindicación 10, caracterizado por utilizar relaciones molares desde uno a uno hasta uno a uno punto cinco para moléculas orgánicas de fórmulas (II) y (III) respectivamente. 13) A synthesis method according to claim 10, characterized in that water is used as solvent. 14) A method according to claim 10, characterized by using molar ratios from one to one to one to one point five for organic molecules of formulas (II) and (III) respectively. 15) Un método de síntesis según la reivindicación 10, caracterizado por realizar la reacción en relación molar de molécula de fórmula (|i) y carbonato de potasio (K2CO3) desde uno a uno hasta uno a seis respectivamente. 15) A synthesis method according to claim 10, characterized by carrying out the reaction in molar ratio of molecule of formula (| i) and potassium carbonate (K2CO3) from one to one to one to six respectively. 16) Un método de síntesis según la reivindicación 10, caracterizado por realizar la reacción agitando la mezcla acuosa hasta un máximo de 72 horas. 16) A synthesis method according to claim 10, characterized by carrying out the reaction by stirring the aqueous mixture for a maximum of 72 hours. 17) Un método de síntesis según la reivindicación 10, caracterizado por realizar la reacción mezclando los compuestos de fórmulas (II), (III), Carbonato de potasio y bromuro de tetrabutilamonio, posteriormente adicionandp;agua para obtener mezcla de reacción homogénea. 17) A synthesis method according to claim 10, characterized in that the reaction is carried out by mixing the compounds of formulas (II), (III), potassium carbonate and tetrabutylammonium bromide, subsequently adding andp ; water to obtain homogeneous reaction mixture. 18) Un método de síntesis según la reivindicación 10, caracterizado por realizar la reacción disolviendo carbonato de potasio en agua, adicionando el compuesto de fórmula (II) y posterior adición del compuesto de fórmula (III) y bromuro de tetrabutilamonio. 18) A synthesis method according to claim 10, characterized by carrying out the reaction by dissolving potassium carbonate in water, adding the compound of formula (II) and subsequent addition of the compound of formula (III) and tetrabutylammonium bromide. 19) Un método de síntesis según la reivindicación 10, caracterizado por obtener benznidazol de alta pureza mediante lavados con agua hasta llevar a pH neutro. 19) A synthesis method according to claim 10, characterized by obtaining high purity benznidazole by washing with water until neutral pH. 20) Un método de síntesis según la reivindicación 10, caracterizado por reutilizar las aguas madres de proceso de síntesis, en presencia de disolvente adicionando los compuestos de fórmulas (II) y (III), para obtener benzmdezol .de elevada pureza. 20) A synthesis method according to claim 10, characterized by reusing the mother liquors of the synthesis process, in the presence of solvent by adding the compounds of formulas (II) and (III), to obtain benzmdezol of high purity. 21 ) Un método de síntesis para la obtención de Benznidazbi ó A/-bencil-2-(2-nitro-1 H- imidazol-1-il)acetamida de fórmula (I), de elevada pureza,
Figure imgf000021_0001
caracterizado por hacer reaccionar 2-nitroimidazol de fórmula (II) con A/-bencil-2- cloroacetamida de fórmula (III), en ausencia o presencia de disolvente, a temperatura ambiente en un rango de 20 a 35°C, llevado a cabo en un tiempo de hasta 72 horas, en presencia de una base y de catalizador,
21) A synthesis method for obtaining Benznidazbi or A / -benzyl-2- (2-nitro-1 H -imidazol-1-yl) acetamide of formula (I), of high purity,
Figure imgf000021_0001
characterized by reacting 2-nitroimidazole of formula (II) with A / -benzyl-2-chloroacetamide of formula (III), in the absence or presence of solvent, at room temperature in a range of 20 to 35 ° C, carried out in a time of up to 72 hours, in the presence of a base and catalyst,
Figure imgf000021_0002
siendo las relaciones molares: desde uno a uno hasta uno a uno punto cinco para moléculas orgánicas de fórmulas (II) y (III) respectivamente, el compuesto de fórmula (II) y carbonato de potasio (K2CO3) desde uno a uno hasta uno á seis respectivamente y el compuesto de fórmula (II) con el bromuro de tetrabutilarfiónio (TBAB) de uno a uno, empleando diferentes órdenes de adición de los reactantes, /éutilización de las aguas madres del proceso de síntesis cuando éste se realiza en presencia de disolvente, adicionando los compuestos de fórmulas (II) y (III), para obtener behznidazol de elevada pureza.
Figure imgf000021_0002
the molar ratios being: from one to one to one to one point five for organic molecules of formulas (II) and (III) respectively, the compound of formula (II) and potassium carbonate (K2CO3) from one to one to one á six respectively and the compound of formula (II) with the tetrabutylaphionium bromide (TBAB) one by one, using different orders of addition of the reactants, / use of the mother liquors of the synthesis process when it is carried out in the presence of solvent , adding the compounds of formulas (II) and (III), to obtain high purity behznidazole.
PCT/SV2019/000002 2018-06-11 2019-06-07 Manufacturing method for benznidazole production and the industrial scaling thereof Ceased WO2019240671A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SV2018005707 2018-06-11
SV2018005707 2018-06-11

Publications (2)

Publication Number Publication Date
WO2019240671A1 true WO2019240671A1 (en) 2019-12-19
WO2019240671A4 WO2019240671A4 (en) 2020-01-30

Family

ID=68501303

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SV2019/000002 Ceased WO2019240671A1 (en) 2018-06-11 2019-06-07 Manufacturing method for benznidazole production and the industrial scaling thereof

Country Status (3)

Country Link
AR (1) AR115046A1 (en)
UY (1) UY38260A (en)
WO (1) WO2019240671A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138529A (en) * 1966-04-18 1969-01-01 Hoffmann La Roche Novel imidazole derivatives and a process for the manufacture thereof
WO2015076760A1 (en) * 2013-11-19 2015-05-28 Ministerio De Educación Production method for producing n-benzyl-2-(2-nitro-1h-imidazol-1-yl)acetamide
WO2015172196A1 (en) * 2014-05-13 2015-11-19 Monash University Heterocyclic compounds and use of same
WO2017205622A1 (en) * 2016-05-25 2017-11-30 Savant Neglected Diseases, Llc Method of making benznidazole

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138529A (en) * 1966-04-18 1969-01-01 Hoffmann La Roche Novel imidazole derivatives and a process for the manufacture thereof
WO2015076760A1 (en) * 2013-11-19 2015-05-28 Ministerio De Educación Production method for producing n-benzyl-2-(2-nitro-1h-imidazol-1-yl)acetamide
WO2015172196A1 (en) * 2014-05-13 2015-11-19 Monash University Heterocyclic compounds and use of same
WO2017205622A1 (en) * 2016-05-25 2017-11-30 Savant Neglected Diseases, Llc Method of making benznidazole

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOGDAL D: "Remarkable fast N-alKylatlon of azaheterocycles under microwave irradiation in dry media", HETEROCYCLES, vol. 45, no. 4, 1997, pages 715 - 722, XP055669105 *
HERNANDEZ-NUNEZ E.: "Synthesis and in vitro trichomonicidal, giardicidal and amebicidal activity of N-acetamide(sulfonamide)-2-methyl-4-nitro-1 H- imidazol", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 44, 2011, pages 2975 - 2984, XP026087806, DOI: 10.1016/j.ejmech.2009.01.005 *

Also Published As

Publication number Publication date
AR115046A1 (en) 2020-11-18
UY38260A (en) 2019-10-01
WO2019240671A4 (en) 2020-01-30

Similar Documents

Publication Publication Date Title
CN110003187A (en) Polyfluoroalkyl substituted benzofuran compound and preparation method thereof
RU2299211C2 (en) Method for preparing sulfamide-substituted imidazotriazinones
US5478949A (en) Process for preparing ondansetron
Brasse et al. A facile, metal-and solvent-free, autoxidative coupling of quinolines with indoles and pyrroles
JP7696630B2 (en) Method for synthesizing antitumor compounds and intermediates therefor
JPH0479349B2 (en)
WO2019240671A1 (en) Manufacturing method for benznidazole production and the industrial scaling thereof
JP2009503034A (en) Process for producing 7H-pyrrolo [2,3-d] pyrimidine derivative
CN108218762B (en) Synthetic method of 2-quaternary carbon indole-3-ketone compound
Chernyshev et al. Acyl and sulfonyl derivatives of 3, 5-diamino-1-R-1, 2, 4-triazoles
EP2895487B1 (en) An improved process for the preparation of 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine from 4-amino-2,5-dimethoxypyrimidine
CN105849115A (en) Pharmaceutical process and intermediates
Temple Jr et al. Diazo-. beta.-azomethine-v-triazine equilibrium
RU2837452C1 (en) Method for synthesis of anticancer compound and intermediate compounds thereof
JP2841143B2 (en) Method for producing 7-azolyl-1H-pyrazolo [1,5-b] -1,2,4-triazoles
CN113956209B (en) Preparation method of NH-1,2, 3-triazole compound
JPH0673058A (en) 5-deazaflavin derivative and its production
JPH08176150A (en) Production of 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole or its salt
CN120647647A (en) Synthesis method of beta-carboline compounds
JPH03215488A (en) Pyrimidobenzimidazole derivative
JP3711625B2 (en) Method for producing 1H-pyrazolo [3,2-c] -1,2,4-triazole compound
CN118878542A (en) Homosildenafil derivative, synthesis method and application thereof
CN118307547A (en) Preparation method of spiro-oxirane oxindole compound
CN120349260A (en) Apatamide intermediate and preparation method and application thereof
Glotova et al. Synthesis and Reactions of 2-Benzoylmethyl-2-phenyl-4, 6-di (phenylimino)-5H-1, 3, 5-dithiazinium Perchlorate.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19819126

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19819126

Country of ref document: EP

Kind code of ref document: A1